Visit-to-visit variability in systolic blood pressure predicts development and progression of diabetic nephropathy, but not retinopathy, in patients with type 2 diabetes

Journal of Diabetes and Its Complications
Toshiko TakaoShoji Kawazu

Abstract

To investigate whether visit-to-visit variability in systolic blood pressure (SBP) can predict development and progression of diabetic nephropathy and retinopathy in patients with type 2 diabetes mellitus (T2DM). From 1995 through 1996, 664 T2DM patients visited our hospital for the first time and were subsequently examined 4 times or more and at least once annually. At first visit, 326 had normoalbuminuria, 644 had an estimated glomerular filtration rate (eGFR) of ≥ 45 ml/min/1.73 m(2), 526 had no diabetic retinopathy and 609 had no severe non-proliferative diabetic retinopathy (NPDR). They were followed through June 2012, at the latest. Ninety patients developed microalbuminuria, 76 showed decrease of eGFR to <45 ml/min/1.73 m(2), 113 developed mild-moderate NPDR and 50 progression to severe NPDR. The unadjusted, age- and sex-adjusted and multivariate-adjusted hazard ratios for development and progression of nephropathy, but not retinopathy, increased across tertiles of the standard deviation (SD) of SBP. Both the SD and coefficient of variation (CV) of SBP were significant predictors of development and progression of nephropathy, but not retinopathy, independently of mean SBP. Visit-to-visit SBP variability is an independent...Continue Reading

References

Dec 29, 2000·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Y HataT Omae
Aug 7, 2001·Journal of Cardiovascular Pharmacology·Z Z ShanD F Su
Sep 24, 2004·The New England Journal of Medicine·Alan S GoChi-yuan Hsu
Apr 3, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Seiichi MatsuoUNKNOWN Collaborators developing the Japanese equation for estimated GFR
Mar 17, 2010·Lancet Neurology·Peter M RothwellUNKNOWN ASCOT-BPLA and MRC Trial Investigators
Aug 28, 2010·Diabetes Care·Eric S KilpatrickStephen L Atkin
Feb 16, 2011·Journal of Clinical Nursing·Heather SkirtonEmma Young
Aug 21, 2012·Current Hypertension Reports·Gianfranco ParatiGrzegorz Bilo
Sep 28, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Kei YokotaKazuomi Kario
Feb 20, 2012·Journal of Diabetes Investigation·Atsunori KashiwagiUNKNOWN Committee on the Standardization of Diabetes Mellitus‐Related Laboratory Testing of Japan Diabetes Society

❮ Previous
Next ❯

Citations

Oct 21, 2015·Kidney Research and Clinical Practice·Francis B AnnorMichael Goodman
Sep 28, 2016·Journal of Diabetes and Its Complications·Min-Woong SohnElly Budiman-Mak
Apr 5, 2016·Journal of Diabetes·Valencia FooCharumathi Sabanayagam
Oct 27, 2018·Current Diabetes Reports·Vincenza Spallone
Feb 13, 2019·Korean Journal of Ophthalmology : KJO·Minji HaYoung Hoon Park
Dec 14, 2019·Cardiovascular Diabetology·Roderick C SliekerJoline W J Beulens

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.